Parent, Guarantor, Non-Guarantor Unaudited Consolidating Condensed Financial Statements - Consolidated Condensed Statements of Cash Flows (Detail) - USD ($)
$ in Thousands |
3 Months Ended |
Mar. 31, 2017 |
Mar. 31, 2016 |
| Cash flows from operating activities: |
|
|
| Net income (loss) |
$ (39,809)
|
$ (95,835)
|
| Adjustments to reconcile net income (loss) |
|
|
| Depreciation and amortization |
32,202
|
35,814
|
| Accretion of contingent consideration |
0
|
419
|
| Provision for reduction in carrying value of certain assets |
0
|
|
| (Gain) loss on disposition of assets |
352
|
60
|
| Deferred income tax expense (benefit) |
(642)
|
63,411
|
| Expenses not requiring cash |
2,150
|
(109)
|
| Equity in net earnings of subsidiaries |
0
|
0
|
| Accounts and notes receivable |
(4,874)
|
(381)
|
| Other assets |
(2,692)
|
(304)
|
| Accounts payable and accrued liabilities |
(15,937)
|
(14,437)
|
| Accrued income taxes |
1,665
|
(3,600)
|
| Net cash provided by operating activities |
(27,585)
|
(15,715)
|
| Cash flows from investing activities: |
|
|
| Capital expenditures |
(14,451)
|
(7,889)
|
| Proceeds from the sale of assets |
46
|
54
|
| Net cash used in investing activities |
(14,405)
|
(7,835)
|
| Cash flows from financing activities: |
|
|
| Payments of contingent consideration |
0
|
(2,000)
|
| Proceeds from Issuance of Common Stock |
25,200
|
0
|
| Proceeds from Issuance of Preferred Stock and Preference Stock |
50,000
|
0
|
| Payments of Stock Issuance Costs |
(2,861)
|
0
|
| Payments Related to Tax Withholding for Share-based Compensation |
(352)
|
(317)
|
| Excess tax benefit from stock-based compensation |
0
|
(753)
|
| Intercompany advances, net |
0
|
0
|
| Net cash used in financing activities |
71,987
|
(2,317)
|
| Net increase (decrease) in cash and cash equivalents |
29,997
|
(25,867)
|
| Cash and cash equivalents, beginning of year |
119,691
|
134,294
|
| Cash and cash equivalents, end of period |
149,688
|
108,427
|
| Parent [Member] |
|
|
| Cash flows from operating activities: |
|
|
| Net income (loss) |
(39,808)
|
(95,835)
|
| Adjustments to reconcile net income (loss) |
|
|
| Depreciation and amortization |
0
|
0
|
| Accretion of contingent consideration |
0
|
0
|
| Provision for reduction in carrying value of certain assets |
0
|
|
| (Gain) loss on disposition of assets |
0
|
0
|
| Deferred income tax expense (benefit) |
(5,641)
|
57,677
|
| Expenses not requiring cash |
1,781
|
2,057
|
| Equity in net earnings of subsidiaries |
21,780
|
16,225
|
| Accounts and notes receivable |
0
|
0
|
| Other assets |
17,984
|
(37,191)
|
| Accounts payable and accrued liabilities |
(34,867)
|
(9,521)
|
| Accrued income taxes |
(5,783)
|
10,680
|
| Net cash provided by operating activities |
(44,554)
|
(56,661)
|
| Cash flows from investing activities: |
|
|
| Capital expenditures |
0
|
0
|
| Proceeds from the sale of assets |
0
|
0
|
| Net cash used in investing activities |
0
|
0
|
| Cash flows from financing activities: |
|
|
| Payments of contingent consideration |
0
|
|
| Proceeds from Issuance of Common Stock |
25,200
|
|
| Proceeds from Issuance of Preferred Stock and Preference Stock |
50,000
|
|
| Payments of Stock Issuance Costs |
2,861
|
|
| Payments Related to Tax Withholding for Share-based Compensation |
352
|
317
|
| Excess tax benefit from stock-based compensation |
0
|
(753)
|
| Intercompany advances, net |
4,106
|
28,815
|
| Net cash used in financing activities |
76,093
|
28,498
|
| Net increase (decrease) in cash and cash equivalents |
31,539
|
(28,163)
|
| Cash and cash equivalents, beginning of year |
65,000
|
73,985
|
| Cash and cash equivalents, end of period |
96,539
|
45,822
|
| Guarantor [Member] |
|
|
| Cash flows from operating activities: |
|
|
| Net income (loss) |
(15,588)
|
(14,313)
|
| Adjustments to reconcile net income (loss) |
|
|
| Depreciation and amortization |
21,188
|
23,125
|
| Accretion of contingent consideration |
0
|
419
|
| Provision for reduction in carrying value of certain assets |
0
|
|
| (Gain) loss on disposition of assets |
216
|
56
|
| Deferred income tax expense (benefit) |
5,165
|
5,185
|
| Expenses not requiring cash |
91
|
33
|
| Equity in net earnings of subsidiaries |
0
|
0
|
| Accounts and notes receivable |
(3,668)
|
(6,637)
|
| Other assets |
(18,296)
|
33,904
|
| Accounts payable and accrued liabilities |
15,591
|
(799)
|
| Accrued income taxes |
7,055
|
(8,905)
|
| Net cash provided by operating activities |
11,754
|
32,068
|
| Cash flows from investing activities: |
|
|
| Capital expenditures |
(10,994)
|
(3,521)
|
| Proceeds from the sale of assets |
0
|
28
|
| Net cash used in investing activities |
(10,994)
|
(3,493)
|
| Cash flows from financing activities: |
|
|
| Payments of contingent consideration |
(2,000)
|
|
| Proceeds from Issuance of Common Stock |
0
|
|
| Proceeds from Issuance of Preferred Stock and Preference Stock |
0
|
|
| Payments of Stock Issuance Costs |
0
|
|
| Payments Related to Tax Withholding for Share-based Compensation |
0
|
0
|
| Excess tax benefit from stock-based compensation |
0
|
0
|
| Intercompany advances, net |
(2,090)
|
(27,187)
|
| Net cash used in financing activities |
(2,090)
|
(29,187)
|
| Net increase (decrease) in cash and cash equivalents |
(1,330)
|
(612)
|
| Cash and cash equivalents, beginning of year |
14,365
|
13,854
|
| Cash and cash equivalents, end of period |
13,035
|
13,242
|
| Non-Guarantor [Member] |
|
|
| Cash flows from operating activities: |
|
|
| Net income (loss) |
(6,193)
|
(1,912)
|
| Adjustments to reconcile net income (loss) |
|
|
| Depreciation and amortization |
11,014
|
12,689
|
| Accretion of contingent consideration |
0
|
0
|
| Provision for reduction in carrying value of certain assets |
0
|
|
| (Gain) loss on disposition of assets |
136
|
4
|
| Deferred income tax expense (benefit) |
(166)
|
549
|
| Expenses not requiring cash |
278
|
(2,199)
|
| Equity in net earnings of subsidiaries |
0
|
0
|
| Accounts and notes receivable |
(1,206)
|
6,256
|
| Other assets |
(2,380)
|
2,983
|
| Accounts payable and accrued liabilities |
3,339
|
(4,117)
|
| Accrued income taxes |
393
|
(5,375)
|
| Net cash provided by operating activities |
5,215
|
8,878
|
| Cash flows from investing activities: |
|
|
| Capital expenditures |
(3,457)
|
(4,368)
|
| Proceeds from the sale of assets |
46
|
26
|
| Net cash used in investing activities |
(3,411)
|
(4,342)
|
| Cash flows from financing activities: |
|
|
| Payments of contingent consideration |
0
|
|
| Proceeds from Issuance of Common Stock |
0
|
|
| Proceeds from Issuance of Preferred Stock and Preference Stock |
0
|
|
| Payments of Stock Issuance Costs |
0
|
|
| Payments Related to Tax Withholding for Share-based Compensation |
0
|
0
|
| Excess tax benefit from stock-based compensation |
0
|
0
|
| Intercompany advances, net |
(2,016)
|
(1,628)
|
| Net cash used in financing activities |
(2,016)
|
(1,628)
|
| Net increase (decrease) in cash and cash equivalents |
(212)
|
2,908
|
| Cash and cash equivalents, beginning of year |
40,326
|
46,455
|
| Cash and cash equivalents, end of period |
40,114
|
49,363
|
| Consolidation, Eliminations [Member] |
|
|
| Cash flows from operating activities: |
|
|
| Net income (loss) |
21,780
|
16,225
|
| Adjustments to reconcile net income (loss) |
|
|
| Depreciation and amortization |
0
|
0
|
| Accretion of contingent consideration |
0
|
0
|
| Provision for reduction in carrying value of certain assets |
0
|
|
| (Gain) loss on disposition of assets |
0
|
0
|
| Deferred income tax expense (benefit) |
0
|
0
|
| Expenses not requiring cash |
0
|
0
|
| Equity in net earnings of subsidiaries |
(21,780)
|
(16,225)
|
| Accounts and notes receivable |
0
|
0
|
| Other assets |
0
|
0
|
| Accounts payable and accrued liabilities |
0
|
0
|
| Accrued income taxes |
0
|
0
|
| Net cash provided by operating activities |
0
|
0
|
| Cash flows from investing activities: |
|
|
| Capital expenditures |
0
|
0
|
| Proceeds from the sale of assets |
0
|
0
|
| Net cash used in investing activities |
0
|
0
|
| Cash flows from financing activities: |
|
|
| Payments of contingent consideration |
0
|
|
| Proceeds from Issuance of Common Stock |
0
|
|
| Proceeds from Issuance of Preferred Stock and Preference Stock |
0
|
|
| Payments of Stock Issuance Costs |
0
|
|
| Payments Related to Tax Withholding for Share-based Compensation |
0
|
0
|
| Excess tax benefit from stock-based compensation |
0
|
0
|
| Intercompany advances, net |
0
|
0
|
| Net cash used in financing activities |
0
|
0
|
| Net increase (decrease) in cash and cash equivalents |
0
|
0
|
| Cash and cash equivalents, beginning of year |
0
|
0
|
| Cash and cash equivalents, end of period |
$ 0
|
$ 0
|